Is gluten sensitivity a no man's land or a fertile crescent for research

American Journal of Gastroenterology

Volumn 105, Issue 1, 2010, Pages 222-223

  Ball, Alex J ^a   Hadjivassiliou, Marios ^b   Sanders, David S ^b  

^a Northern General Hospital   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLIADIN ANTIBODY; GLUTEN;

CELIAC DISEASE; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; DISEASE PREDISPOSITION; DISEASE SEVERITY; GASTROINTESTINAL SYMPTOM; GLUTEN FREE DIET; HUMAN; IRRITABLE COLON; LETTER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSORIASIS;

CELIAC DISEASE; COLONIC DISEASES, FUNCTIONAL; GLUTENS; HUMANS; INCIDENCE; IRRITABLE BOWEL SYNDROME; PROGNOSIS; QUALITY OF LIFE; RISK FACTORS;

EID: 73849133265     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1038/ajg.2009.565     Document Type: Letter

References (5)

1. Verdu E, Armstrong D, Murray J. Between celiac disease and irritable bowel syndrome: the " no man's land " of gluten sensitivity. Am J Gastroenterol 2009;104:1587-1594
2. O 'Leary C, Wieneke P, Buckley S et al. Celiac disease and irritable bowel-type symptoms. Am J Gastroenterol 2002;97: 1463-1467
3. Hadjivassiiliou M, Kandler R, Chattopadhyay A et al. Dietary treatment of gluten neuropathy. Muscle nerve 2006;34:762-766
4. Michaelsson G, Gerden B, Hagforsen E et al. Psoriasis patients with antibodies to gliadin can be improved by a gluten-free diet. Br J Derma-tol 2000;142:44-51.
5. Ferguson A, Arranz E, O'Mahony S. Clinical and pathological spectrum of coeliac disease\-active, silent, latent, potential. Gut 1993;34:150-151